Breast Cancer
New breast cancer study findings reported from L. Montella and co-authors
Published in Cancer Weekly, June 15th, 2010
Current study results from the report, 'Once-per-cycle pegfilgrastim in breast cancer patients treated with docetaxel/epidoxorubicin/cyclophosphamide,' have been published. "The incidence of neutropenia following combination chemotherapy is significant in breast cancer and impairs patients' quality of life. Colony-stimulating factors significantly decrease the risk of febrile neutropenia (FN)," scientists in Naples, Italy report.
"Aim of the present study was to assess the efficacy and safety profile of once-per-cycle pegfilgrastim in reducing FN in breast cancer patients treated with docetaxel (75 mg/m2), epidoxorubicin (75 mg/m2),...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2010-06-15)
More Articles from Cancer Weekly
- Bowel Cancer
Scientists move closer to pinpointing gene involved in bowel cancer spread - Colon Cancer
Investigators at Memorial Sloan-Kettering Cancer Center have published new data on colon cancer - Kidney Cancer
New kidney cancer study findings have been reported by researchers at National Cancer Institute - Proteomics
Studies from University Hospital, Institute for Pathology yield new data on proteomics - Prostate Cancer
Investigators at Fred Hutchinson Cancer Research Center, Division of Public Health Sciences publish new data on prostate cancer - Esophageal Cancer
Reports summarize esophageal cancer study results from O. Pech and co-researchers - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
